Status:
UNKNOWN
Management of Frailty in Older Adults With Turmeric and Tulsi Supplements
Lead Sponsor:
Composite Interceptive Med Science
Conditions:
Frail Elderly Syndrome
Eligibility:
All Genders
65-90 years
Phase:
NA
Brief Summary
The aim of this study is to determine the efficacy of turmeric and tulsi polyherbal formulation in the management of frailty in the elderly population.
Detailed Description
Frailty is a wasting syndrome of old age that leaves a person vulnerable to falls, functional decline, morbidity and mortality. Reducing the severity of frailty will provide large benefits for individ...
Eligibility Criteria
Inclusion
- Subjects above the age of 65 years, providing written informed consent.
- Meeting three or more Cardiovascular health study frailty criteria
- Mild or no cognitive impairment (defined as a Mini-Mental State Examination score \>23),
- Able to walk without personal assistance and no other physical limitations that can limit participation and adherence, particularly to exercise intervention program
Exclusion
- People will be ineligible to participate in the trial if they:
- Live in a residential aged care facility
- Severe audio-visual impairment
- Progressive, degenerative neurologic disease like Parkinsonism, fits/ epilepsy, etc.
- Rapidly progressive or terminal illness under palliative care with life expectancy less than 12 months
- History of alcohol abuse or any other substance abuse
- Severely affect muscle/joint dysfunction resulting in disability
- Hospital admission in the past 3 months
- Regular physical training or physiotherapy or current participation in a vigorous exercise or weight-training program more than once per week
- Undergoing therapeutic diet incompatible with nutritional supplementation
- In the opinion of research clinician, the intervention is deemed to be potentially hazardous for the subject, such as serious cardiac and pulmonary disease.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03365310
Start Date
July 1 2018
End Date
July 30 2018
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mazumdar Shaw Medical Centre
Bangalore, Karnataka, India, 560099